Cargando…

Perioperative Landiolol Administration reduces Atrial Fibrillation after Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

INTRODUCTION: Postoperative atrial fibrillation (POAF) is one of the most common complications after cardiac surgery. Patients who develop POAF have a prolonged stay in the intensive care unit and hospital and an increased risk of postoperative stroke. Many guidelines for the management of cardiac s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Atsuhiro, Hamasaki, Toshimitsu, Kitakaze, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003343/ https://www.ncbi.nlm.nih.gov/pubmed/24756366 http://dx.doi.org/10.1007/s12325-014-0116-x

Ejemplares similares

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
por: Nakanishi, Kazuhiro, et al.
Publicado: (2013)

Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis
por: Cafaro, Teresa, et al.
Publicado: (2023)

Perioperative Administration of an Intravenous Beta-Blocker Landiolol Hydrochloride in Patients with Lung Cancer: A Japanese Retrospective Exploratory Clinical Study
por: Sakamoto, Atsuhiro, et al.
Publicado: (2019)

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Preventive Effect of Intraoperative Landiolol Administration on Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting
por: Osumi, Masahiro, et al.
Publicado: (2014)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting
por: Domanovits, Hans, et al.
Publicado: (2018)

Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
por: Caspersen, Edouard, et al.
Publicado: (2023)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study)
por: Sasaki, Konosuke, et al.
Publicado: (2020)

Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Influence of the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Chanson-Rolle, Aurelie, et al.
Publicado: (2015)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

Erratum to: Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
por: Kinugawa, Koichiro, et al.
Publicado: (2014)

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
por: Hariri, Geoffroy, et al.
Publicado: (2021)

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
por: Dan, Gheorghe-Andrei
Publicado: (2022)

Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy
por: Higuchi, Satoshi, et al.
Publicado: (2019)

Intravenous landiolol for the prevention of atrial fibrillation after aortic root, ascending aorta, and aortic arch surgery: A propensity score-matched analysis
por: Kaminohara, Jun, et al.
Publicado: (2022)

A comparison of bolus injection of landiolol versus oral administration of propranolol before cardiac computed tomography
por: Nakamura, Yoshitaka, et al.
Publicado: (2014)

Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
por: Wang, Michael Ke, et al.
Publicado: (2022)

Perioperative predictors of atrial fibrillation
por: İşcan, Şahin, et al.
Publicado: (2018)

Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
por: Yamamoto, Haruko, et al.
Publicado: (2019)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment　― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020)

Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
por: Park, Bo Eun, et al.
Publicado: (2020)

Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis
por: Wang, Michael K., et al.
Publicado: (2021)

Atrial fibrillation after cardiac surgery
por: İşcan, Şahin, et al.
Publicado: (2015)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis
por: Zhu, Zhipeng, et al.
Publicado: (2018)

New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?—Authors’ reply
por: Kawczynski, Michal J, et al.
Publicado: (2021)

Landiolol reduces hemodynamic responses to bronchoscopy-assisted suctioning in intubated ICU patients
por: Tochikubo, Junpei, et al.
Publicado: (2014)

Perioperative statin administration with decreased risk of postoperative atrial fibrillation, but not acute kidney injury or myocardial infarction: A meta-analysis
por: Zhen-Han, Li, et al.
Publicado: (2017)

Role of clonidine in perioperative acute atrial fibrillation
por: Garg, Vishal, et al.
Publicado: (2011)

Perioperative dexmedetomidine administration does not reduce the risk of acute kidney injury after non-cardiac surgery: a meta-analysis
por: Hu, Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fkgnucdcf5utruvg520enk6tgh